Physician profile
Matthew Kaminsky
NPI 1851709091
$1,794.68
in general payments reported to CMS, 2019-2025
18 companies · $75.45 in 2025
The $75.45 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $136 · 2021: $375 · 2022: $425 · 2023: $614 · 2024: $63.98 · 2025: $75.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $753.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $388.61 | 2022-2025 | |
| Alcon Vision LLC | $349.14 | 2021-2023 | Clareon, Centurion |
| Aerie Pharmaceuticals, INC. | $148.64 | 2020-2021 | |
| Kala Pharmaceuticals, INC. | $146.70 | 2021 | |
| Allergan, INC. | $140.08 | 2020-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $136.70 | 2022-2023 | Intralase Fs Femtosec Laser |
| Glaukos Corporation | $111.62 | 2022-2024 | Idose, Photrexa Cross-Linking Kit |
| Eyevance Pharmaceuticals LLC | $62.01 | 2019 | |
| Novartis Pharmaceuticals Corporation | $57.26 | 2022-2023 | |
| Coopervision INC. | $50.30 | 2023-2024 | Myday Contact Lens |
| The Walman Optical Company | $43.79 | 2019 | |
| Oyster Point Pharma, INC. | $38.71 | 2023-2025 | Tyrvaya, Ryzumvi |
| Mallinckrodt Hospital Products INC. | $29.38 | 2023 | Acthar |
| Astellas Pharma US INC | $25.25 | 2023 | |
| Sun Pharmaceutical Industries INC. | $17.71 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $16.72 | 2021 | |
| Vantage Technology LLC | $16.04 | 2023 | |
| Biotissue Holdings INC. | $16.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Kaminsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.